Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS
AssigneeNymox Corporation
InventorPaul Averback
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of enhancing the therapeutic efficacy of Fexapotide Triflutate (TF) in treating LUTS, both irritative and obstructive, that include administering a composition comprising FT at least twice over a period spanning more than one year. The methods are capable of providing an enhanced therapeutic effect in treating nocturia, and in improving urinary flow, when compared to the therapeutic effect achieved by administration of the same or twice the total amount of FT administered.
Claims19
A method of enhancing the therapeutic efficacy of Fexapotide Triflutate (FT) in treating Lower Urinary Tract Symptoms (LUTS), comprising:
- (i) identifying a mammal having LUTS that does not also have benign prostatic hyperplasia (BPH);
- and (ii) first administering a composition comprising FT to the mammal;
- and subsequently administering a composition comprising FT to the mammal at least more than one year after the first administration.
A method of treating irritative symptoms of mammals having Lower Urinary Tract Symptoms (LUTS), comprising:
- (a) identifying a mammal having irritative symptoms of LUTS that does not also have benign prostatic hyperplasia (BPH);
- (b) administering a first composition comprising Fexapotide Triflutate (FT) to the mammal;
- and
- (c) administering a second composition comprising FT to the mammal at least more than one year after administering the first composition.
A method of treating obstructive symptoms of mammals with Lower Urinary Tract Symptoms (LUTS), comprising:
- (a) identifying a mammal having obstructive symptoms of LUTS that does not also have benign prostatic hyperplasia (BPH);
- (b) administering a first composition comprising Fexapotide Triflutate (FT) to the mammal;
- and
- (c) administering a second composition comprising FT to the mammal at least more than one year after administering the first composition.
Dependencies are inferred from the claim text.